Quantcast

Latest Biologic Stories

2014-02-20 04:20:55

-- More than 200 artists inspired by patients in more than 40 countries NORTH CHICAGO, Ill., Feb. 20, 2014 /PRNewswire/ -- AbbVie today announced the launch of 'Perspectives - Art, Inflammation and Me', an initiative designed to add a different dimension to the current understanding of immune-mediated inflammatory diseases (IMIDs) and their impact on patients and society. More than 100 unique artistic expressions from the initiative are being debuted at the 9th Congress of the...

2014-02-19 08:31:36

- BioMotiv Establishes Kodosil Bio to Develop Collaboration Compounds - SAN DIEGO and CLEVELAND, Feb. 19, 2014 /PRNewswire/ -- BioAtla, a global biotechnology company focused on the development of conditionally active biologics (CABs), and BioMotiv, the therapeutics accelerator for The Harrington Project for Discovery & Development, today announced that BioAtla licensed exclusive worldwide rights to BioMotiv to develop and commercialize its TH22 pathway-directed antibody compound...

2014-02-19 08:30:00

ALBANY, New York, February 19, 2014 /PRNewswire/ -- ResearchMoz.us includes new market research report "Hepatitis C Therapeutics in Major Developed Markets to 2019 [http://www.researchmoz.us/hepatitis-c-therapeutics-in-major-developed-markets-to-2019-outstanding-recent-approvals-and-late-stage-pipeline-to-transform-clinical-and-commercial-landscape-report.html ] " to its huge collection of research reports. Researchmoz presents this most up-to-date research on...

2014-02-17 23:02:51

Biosimilars Products Market report is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. (http://www.marketsandmarkets.com/Market-Reports/biosimilars-40.html) (PRWEB) February 17, 2014 The “Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) -...

2014-02-13 16:27:47

ROCKVILLE, Md., Feb. 13, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of product candidates focused on the prevention and treatment of serious infectious and other diseases, announced today that in view of the unusual market activity in the Company's stock, the NYSE MKT (the "Exchange") has contacted the Company in accordance with its usual practice. The Company stated that its policy is not to comment on unusual market activity. About Synthetic...

2014-02-11 12:25:31

DUBLIN, February 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/6mkhtx/biosimilars) has announced the addition of the "Biosimilars Market by Product & Application - Global Forecast to 2018" [http://www.researchandmarkets.com/research/6mkhtx/biosimilars ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global market is segmented on the basis of products, applications, and...

2014-02-08 16:20:37

SCOTTSDALE, Ariz., Feb. 8, 2014 /PRNewswire/ -- Applied Biologics LLC, an integrated biotechnology company engaged in the development and commercialization of innovative biologic products derived from the placental tissues, is pleased to announce that Applied Biologics has been awarded a GSA Schedule 20 contract and is now certified to provide goods and services to the Federal government on a national scale. (Logo: http://photos.prnewswire.com/prnh/20140206/LA60748LOGO )...

2014-02-06 23:24:53

MarketResearchReports.Biz announces addition of new report “Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth Description” to its database. Visit: http://www.marketresearchreports.biz/analysis/186872 Albany, NY (PRWEB) February 06, 2014 Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth Description Research...

2014-02-06 16:27:32

SCOTTSDALE, Ariz., Feb. 6, 2014 /PRNewswire/ -- Applied Biologics LLC, an integrated biotechnology company engaged in the development and commercialization of innovative biologic products derived from the placental tissues, is pleased to announce the appointment of Edward Britt as President. (Logo: http://photos.prnewswire.com/prnh/20140206/LA60748LOGO) Since early 2013, Mr. Britt has been an active and engaged part of both the board and the Company. Britt continues his work with...

2014-02-06 08:29:30

WEST CONSHOHOCKEN, Pa., Feb. 6, 2014 /PRNewswire/ -- AFcell Medical has announced that it will now operate under the name Liventa Bioscience, effective immediately. The new name is a derivation of the words "live" and "placenta" and better reflects the company's mission to improve the lives of patients through its placental-based advanced biologic tissue forms. "We are very excited to announce our new name and corporate identity," said Liventa's Chief Executive Officer, Robin...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.